Griffith R S, Brier G L, Wolny J D
Antimicrob Agents Chemother. 1977 May;11(5):813-6. doi: 10.1128/AAC.11.5.813.
Erythromycin and cefamandole have exhibited synergistic activity against eight strains of Bacteroides fragilis subsp. fragilis. In concentrations of only 0.25 to 0.5 mug of erythromycin per ml (easily obtainable with oral therapy), less than 0.4 mug (0.015 to 1.0) of cefamandole per ml inhibited the B. fragilis strains. In the presence of the erythromycin, the potency of cefamandole was increased more than 100-fold. On the basis of the mechanism of action of these two antibiotics, the synergism may be related to inhibition of beta-lactamase formation by the erythromycin, removal of the bacterial cell wall by the cefamandole permitting erythromycin penetration to the ribosomal level, and decreasing inoculum effect.
红霉素和头孢孟多对8株脆弱拟杆菌脆弱亚种表现出协同活性。每毫升仅含0.25至0.5微克红霉素(口服治疗很容易达到此浓度),每毫升低于0.4微克(0.015至1.0)的头孢孟多就能抑制脆弱拟杆菌菌株。在红霉素存在的情况下,头孢孟多的效力增加了100多倍。基于这两种抗生素的作用机制,这种协同作用可能与红霉素抑制β-内酰胺酶形成、头孢孟多去除细菌细胞壁使红霉素能够渗透到核糖体水平以及降低接种量效应有关。